Developing and Implementing a Pharmacist-Managed, Telephone-Based Helicobacter pylori Clinic

Susan L. Ravnan, Marcus C. Ravnan, and Bruce A. Manzo

Disclosures

Am J Health Syst Pharm. 2002;59(8) 

In This Article

Experience with the Program

Within three months, 42 patients were evaluated and appropriately treated. Treatment compliance, evaluated by patient response, was 100%, and few adverse effects were noted. Because we focused on drug interactions and medication safety, no significant drug-drug or drug-food interactions were recorded. Although not formally evaluated, patient satisfaction with this clinic was recognized; patients remarked about the convenience of home assessment and follow-up, the provision of education and awareness, and the individualized attention they received. Symptomatic improvement was noted in 14 (33%) of 42 patients, but overall improvement was difficult to determine because many patients were asymptomatic or mildly symptomatic before initiating therapy. In addition, many patients were on acid-suppressive therapy, which may have interfered with baseline symptom scores. Of the 42, only 3 patients were referred to their primary care provider for further evaluation; at one month, acid-suppressive therapy had not been reinitiated for any of the patients.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....